Shoulder Innovations announced the successful first human use of the InSet Humeral short stem system. The device received FDA 510(k) clearance in 2018 for use in total and partial shoulder arthroplasty.
The InSet Shoulder features streamlined instrumentation and a proprietary coating for implant fixation. It can be used with the company's InSet glenoid implant as a bone-sparing option to treat humeral or glenoid deformities.
David Blue, Chief Commercial Officer of Shoulder Innovations, said, "This is an exciting day for Shoulder Innovations as we continue to roll out the next phase of the InSet technology platform. This combined with our very successful InSet Glenoid implant provides the next generation of innovative technology for shoulder arthroplasty, while providing the smallest instrument and implant footprint on the market today."
Source: Shoulder Innovations, LLC